BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Chemical Company--Rats

Expert replies
by kris610 » Sun Jul 19, 2009 6:37 am
A chemical company claims that, since only one of 520 rats that were given high doses of a new artificial sweetener developed cancer while all the others remained healthy, the sweetener is not carcinogenic for human beings and ought to be approved for human consumption.

Which of the following, if true, most strongly supports the chemical company’s claim?

(A) Chemicals that are carcinogenic for rats are usually also carcinogenic for other animals, such as guinea pigs, used in experiments.

(B) The spontaneous incidence of cancer in this particular strain of rat is approximately one in 540.

(C) Tests conducted on a certain strain of mouse show that, of 500 mice given a dose of sweetener similar to that given the rats, 53 developed cancer.

(D) Certain chemicals that are carcinogenic for human beings have been shown not to be carcinogenic for rats.

(E) The average lifespan of the strain of rat used in the experiment is 2 years; the chemical company terminated the experiment when the rats were 13 months old.
Join the discussion
Source: — Critical Reasoning |

by mgmt_gmat » Sun Jul 19, 2009 7:07 am
IMO (D)
Join the discussion

by raghavsarathy » Sun Jul 19, 2009 7:39 am
IMO - A

C weakens the argument by showing that the incidence of cancer was much higher in mice.

B ,D and E are OOS
Join the discussion

by kamalsinghy » Sun Jul 19, 2009 8:01 am
IMO B.

A. Out of scope.
C. Weakening the argument.
D. It's not strengthening rather talking about of reversal effect.
E. Weakening the argument.
Join the discussion

by Estone29 » Sun Jul 19, 2009 10:01 am
IMO - B

B. If true then it shows that the sweetener most likely didn't even cause the cancer, but the fact that 1 in 520 rats will develop cancer naturally. Thus, strengthening the chemical companies claims.
Join the discussion

by kris610 » Sun Jul 19, 2009 2:15 pm
OA is [/spoiler]
Join the discussion

by khanshainur » Sun May 15, 2016 11:34 pm
I believe the correct answer should be B
Join the discussion